Standard BioTools Inc (NASDAQ:LAB)
| 1.95 Delayed Data As of Mar 31 |  -0.04 / -2.01%Today’s Change | 0.92 Today|||52-Week Range 4.23 | +66.67% Year-to-Date |
Latest LAB News | Press Releases
No recent news for Standard BioTools Inc.
Today’s Trading
| Previous close | 1.99 |
| Today’s open | 2.00 |
| Day’s range | 1.93 - 2.00 |
| Volume | 4,504 |
| Average volume (3 months) | 245,542 |
| Market cap | $158.1M |
Data as of 4:00pm ET, 03/31/2023
Growth & Valuation
| Earnings growth (last year) | -210.61% |
| Earnings growth (this year) | +56.79% |
| Earnings growth (next 5 years) | -8.05% |
| Revenue growth (last year) | -24.99% |
| P/E ratio | NM |
| Price/Sales | 0.94 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Standard BioTools In... | -0.04 | -2.01% |
| HBIOHarvard Bioscience I... | -0.01 | -0.24% |
| BFNHBioForce Nanoscience... | 0.00 | 0.00% |
| --Chromocure Inc | 0.00 | 0.00% |
Data as of 3:59pm ET, 03/31/2023
Financials
| Next reporting date | May 4, 2023 |
| EPS forecast (this quarter) | -$0.06 |
| Annual revenue (last year) | $97.9M |
| Annual profit (last year) | -$190.1M |
| Net profit margin | -194.08% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
